Manufacturing and Production

Showing 15 posts of 5813 posts found.

dna-163466_1280

Biotage launches new automated platform for plasmid DNA purification

June 22, 2021 Manufacturing and Production

Biotage has launched PhyPrep, a new automated platform for plasmid DNA purification. With the new Biotage PhyPrep platform, the automated …
takeda_wien

Takeda collaboration to optimise biopharmaceutical manufacturing announced

June 22, 2021 Manufacturing and Production Takeda, collaboration, manufacturing

A 36-month joint project between Takeda’s manufacturing site in Vienna, the Research Center Pharmaceutical Engineering (RCPE), InSilicoTrials, and the University …
andrei_r_-_shutterstock_1935537274_720

LegoChem and Iksuda expand License Agreement for antibody drug conjugates

June 22, 2021 Manufacturing and Production ADC, License Agreement, deal, technology

Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …

Insect-based vaccine production platform validated by EMA

June 22, 2021 Manufacturing and Production Insect-based, Vaccine, production, technology

Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …

GSK’s ViiV and Halozyme to collaborate on ‘ultra-long acting’ HIV drugs

June 22, 2021 Manufacturing and Production GSK, HIV, ViiV Healthcare

ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline (GSK), is to collaborate with Halozyme Therapeutics, giving it exclusive …
az

AstraZeneca antibody fails to prevent COVID in exposed patients

June 15, 2021 Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial

AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …

Novo Holdings acquires BBI Group in £400 million deal

June 15, 2021 Manufacturing and Production acqusition, deal, finance

Novo Holdings, a holding company of the Novo Group, has acquired BBI Group from Exponent for an enterprise value of …

Biogen Phase III choroideremia study did not meet primary endpoint

June 15, 2021 Manufacturing and Production Biogen, choroideremia, phase III

Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …
integration_of_nvd-001_in_intervertebral_body_cage_fusion

Bone regeneration stem cell “putty” sees positive results in trials

June 15, 2021 Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology

Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …

Cognito Therapeutics initiates Down syndrome Alzheimer’s study

June 15, 2021 Manufacturing and Production

Cognito Therapeutics are going to run a second digital therapeutic study evaluating individuals who have the genetic rare disease, Down …

Phase III trial supports the potential use of Cabometyx for thyroid cancer

June 8, 2021 Manufacturing and Production

Ipsen and Exelixis have announced detailed results from the Phase III COSMIC-311 pivotal trial of Cabozantinib in patients with previously …
hand-3666974_1280

FDA approves first new Alzheimer’s drug in two decades

June 8, 2021 Manufacturing and Production

Biogen’s controversial new drug, aducanumab, has been accepted by the FDA, making it the first Alzheimer’s drug to be approved …
img_4190-e1376666350337-web

MHRA approves venetoclax as acute myeloid leukemia treatment

June 8, 2021 Manufacturing and Production EC, EU, MHRA, leukemia

The MHRA has announced its approval for AbbVie’s venetoclax, in combination with a hypomethylating agent, for the treatment of newly …
merckwindow_web

MSD announce new data from advanced renal cell carcinoma trial

June 8, 2021 Manufacturing and Production MSD, rcc

Merk (MSD) has announced positive data from its Phase III Clear/Keynote-581 trial on Keytruda (pembrolizumab) plus Lenvima (lenvatinib), and Lenvima …

New NICE recommendation for Astellas prostate cancer drug

June 8, 2021 Manufacturing and Production Astellas, NICE, prostate cancer

A newly published Final Appraisal Determination by NICE has recommended Astellas’ Xtandi (enzalutamide) plus androgen deprivation therapy (ADT), as an …

Latest content